Tag Archives: zelforab

February, 2015

  • 19 February

    Roche’s Skin Cancer Candidate Granted Priority Review

    Roche Holding AG said that its skin cancer treatment has been granted Priority Review by the US Food and Drug Administration (FDA). The agency has accepted and granted priority review for the company’s New Drug Application (NDA) for cobimetinib in combination with Zelboraf (vemurafenib) for the treatment of people with …